Teva Pharmaceutical Industries Ltd (TEVA)
18.64
+0.19
(+1.03%)
USD |
NYSE |
Nov 04, 16:00
18.79
+0.15
(+0.80%)
After-Hours: 20:00
Teva Pharmaceutical Industries Shareholders Equity (Quarterly): 6.359B for June 30, 2024
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
Date | Value |
---|---|
June 30, 2024 | 6.359B |
March 31, 2024 | 7.278B |
December 31, 2023 | 7.506B |
September 30, 2023 | 6.929B |
June 30, 2023 | 7.052B |
March 31, 2023 | 7.86B |
December 31, 2022 | 7.804B |
September 30, 2022 | 8.767B |
June 30, 2022 | 9.037B |
March 31, 2022 | 9.344B |
December 31, 2021 | 10.28B |
September 30, 2021 | 10.47B |
June 30, 2021 | 10.32B |
March 31, 2021 | 10.00B |
December 31, 2020 | 10.03B |
September 30, 2020 | 9.593B |
June 30, 2020 | 13.85B |
March 31, 2020 | 13.53B |
December 31, 2019 | 13.97B |
September 30, 2019 | 13.79B |
June 30, 2019 | 14.12B |
March 31, 2019 | 14.73B |
December 31, 2018 | 14.71B |
September 30, 2018 | 17.73B |
June 30, 2018 | 17.94B |
Date | Value |
---|---|
March 31, 2018 | 18.62B |
December 31, 2017 | 17.36B |
September 30, 2017 | 28.67B |
June 30, 2017 | 27.99B |
March 31, 2017 | 34.02B |
December 31, 2016 | 33.34B |
September 30, 2016 | 35.13B |
June 30, 2016 | 30.15B |
March 31, 2016 | 30.44B |
December 31, 2015 | 29.77B |
September 30, 2015 | 22.74B |
June 30, 2015 | 23.04B |
March 31, 2015 | 22.64B |
December 31, 2014 | 23.31B |
September 30, 2014 | 23.63B |
June 30, 2014 | 23.54B |
March 31, 2014 | 22.97B |
December 31, 2013 | 22.56B |
September 30, 2013 | 22.31B |
June 30, 2013 | 21.52B |
March 31, 2013 | 22.71B |
December 31, 2012 | 22.77B |
September 30, 2012 | 22.93B |
June 30, 2012 | 22.75B |
March 31, 2012 | 23.05B |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
6.359B
Minimum
Jun 2024
13.97B
Maximum
Dec 2019
9.473B
Average
9.344B
Median
Mar 2022
Shareholders Equity (Quarterly) Benchmarks
Amicus Therapeutics Inc | 132.52M |
Compugen Ltd | 58.34M |
Pluri Inc | 0.096M |
Can Fite Biofarma Ltd | 6.243M |
BiomX Inc | 27.42M |
Shareholders Equity (Quarterly) Related Metrics
Total Assets (Quarterly) | 41.34B |
Total Liabilities (Quarterly) | 34.78B |
Debt to Equity Ratio | 2.931 |
Current Ratio | 0.8922 |
Net Debt Paydown Yield | 2.23% |